150 related articles for article (PubMed ID: 33249627)
1. Prognostic Value of B-Type Natriuretic Peptide in Liver Transplant Patients: Implication in Posttransplant Mortality.
Kwon HM; Moon YJ; Kim KS; Shin WJ; Huh IY; Jun IG; Song JG; Hwang GS
Hepatology; 2021 Jul; 74(1):336-350. PubMed ID: 33249627
[TBL] [Abstract][Full Text] [Related]
2. Combined B-type Natriuretic Peptide as strong predictor of short-term mortality in patients after Liver Transplantation.
Chung HS; Woo A; Chae MS; Hong SH; Park CS; Choi JH; Jo YS
Int J Med Sci; 2021; 18(12):2500-2509. PubMed ID: 34104081
[No Abstract] [Full Text] [Related]
3. Transient decrease in B-type natriuretic peptide level after liver transplantation does not ensure favorable post-transplant 30-day outcomes.
Kwon HM; Kim JH; Kang SJ; Hwang GS
Anesth Pain Med (Seoul); 2023 Apr; 18(2):169-176. PubMed ID: 37183285
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Preoperative Brain Natriuretic Peptide Serum Levels in Liver Transplantation.
Toussaint A; Weiss E; Khoy-Ear L; Janny S; Cohen J; Delefosse D; Guillemet L; Gayat E; Paugam-Burtz C
Transplantation; 2016 Apr; 100(4):819-24. PubMed ID: 26845306
[TBL] [Abstract][Full Text] [Related]
5. Preoperative high-sensitivity troponin I and B-type natriuretic peptide, alone and in combination, for risk stratification of mortality after liver transplantation.
Moon YJ; Kwon HM; Jung KW; Kim KS; Shin WJ; Jun IG; Song JG; Hwang GS
Korean J Anesthesiol; 2021 Jun; 74(3):242-253. PubMed ID: 32846082
[TBL] [Abstract][Full Text] [Related]
6. Increased B-type natriuretic peptide during liver transplantation: relationship to invasively measured hemodynamic parameters.
Huh IY; Kim YK; Shin WJ; Park SE; Bang JY; Hwang GS
Transplant Proc; 2012 Jun; 44(5):1318-22. PubMed ID: 22664008
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.
Di Marca S; Rando A; Cataudella E; Pulvirenti A; Alaimo S; Terranova V; Corriere T; Pisano M; Di Quattro R; Ronsisvalle ML; Giraffa CM; Giordano M; Stancanelli B; Malatino L
Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):636-642. PubMed ID: 29625779
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
Mauro E; Crespo G; Martinez-Garmendia A; Gutierrez-Acevedo MN; Diaz JM; Saidman J; Bermudez C; Ortiz-Patron J; Garcia-Olveira L; Zalazar F; Narvaez A; Spina JC; Orta R; Savluk L; Piano S; Marciano S; Gadano A
Transplantation; 2020 Jul; 104(7):e188-e198. PubMed ID: 32150034
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
[TBL] [Abstract][Full Text] [Related]
10. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
11. B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis: A Substudy of the TOPAS Study.
Dahou A; Clavel MA; Capoulade R; O'Connor K; Ribeiro HB; Côté N; Le Ven F; Rodés-Cabau J; Dumesnil JG; Mathieu P; Pibarot P
JACC Cardiovasc Imaging; 2018 Jul; 11(7):939-947. PubMed ID: 28917673
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of neutrophil gelatinase-associated lipocalin and B-type natriuretic in patients with ST-elevation myocardial infarction treated by primary PCI: a prospective observational cohort study.
Helanova K; Littnerova S; Kubena P; Ganovska E; Pavlusova M; Kubkova L; Jarkovsky J; Pavkova Goldbergova M; Lipkova J; Gottwaldova J; Kala P; Toman O; Dastych M; Spinar J; Parenica J
BMJ Open; 2015 Oct; 5(10):e006872. PubMed ID: 26438132
[TBL] [Abstract][Full Text] [Related]
13. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide and risk of sudden death in patients with hypertrophic cardiomyopathy.
Minami Y; Haruki S; Kanbayashi K; Maeda R; Itani R; Hagiwara N
Heart Rhythm; 2018 Oct; 15(10):1484-1490. PubMed ID: 29709578
[TBL] [Abstract][Full Text] [Related]
15. B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure.
York MK; Gupta DK; Reynolds CF; Farber-Eger E; Wells QS; Bachmann KN; Xu M; Harrell FE; Wang TJ
J Am Coll Cardiol; 2018 May; 71(19):2079-2088. PubMed ID: 29747827
[TBL] [Abstract][Full Text] [Related]
16. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD.
Stolz D; Breidthardt T; Christ-Crain M; Bingisser R; Miedinger D; Leuppi J; Mueller B; Tamm M; Mueller C
Chest; 2008 May; 133(5):1088-94. PubMed ID: 18339792
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy.
El-Saed A; Voigt A; Shalaby A
Clin Cardiol; 2009 Nov; 32(11):E33-8. PubMed ID: 19816874
[TBL] [Abstract][Full Text] [Related]
18. Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS).
Cleland JGF; Teerlink JR; Davison BA; Shoaib A; Metra M; Senger S; Milo O; Cotter G; Bourge RC; Parker JD; Jondeau G; Krum H; O'Connor CM; Torre-Amione G; van Veldhuisen DJ; McMurray JJV;
Eur J Heart Fail; 2017 Jun; 19(6):739-747. PubMed ID: 28296139
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
[TBL] [Abstract][Full Text] [Related]
20. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
